Skip to main content
Log in

Comparison between the gonadotropin-releasing hormone antagonist protocol and the gonadotropin-releasing hormone agonist long protocol for controlled ovarian hyperstimulation in the first in vitro fertilization–embryo transfer cycle in an unspecified population of infertile couples

  • Original Article
  • Published:
Reproductive Medicine and Biology

Abstract

Purpose

We aimed to compare the efficacy of a gonadotropin-releasing hormone (GnRH) antagonist protocol and a GnRH agonist long protocol used in the first in vitro fertilization–embryo transfer (IVF–ET) cycle in an unspecified population of infertile couples.

Methods

Fifty and 34 patients were treated with a GnRH agonist long protocol (agonist group) and GnRH antagonist protocol (antagonist group), respectively, in the first treatment cycle. The primary and secondary outcome measures were cumulative live birth rates after fresh and cryopreserved–thawed ETs and incidence of grades II and III ovarian hyperstimulation syndrome (OHSS), respectively.

Results

No significant differences were observed in clinical pregnancy rates (38.0 vs. 32.4%) and live birth rates (22.0 vs. 23.5%), which included both fresh and cryopreserved–thawed ETs, between the 2 groups. However, the incidence of grade III OHSS was significantly lower with the GnRH antagonist protocol than the GnRH agonist long protocol.

Conclusions

Used in the first IVF–ET cycle in an unspecified population of infertile patients, the GnRH antagonist protocol showed the same clinical outcome as the GnRH agonist long protocol.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Griesinger G, Felberbaum R, Diedrich K. GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians’ second choice? Data from the German National IVF Registry. Hum Reprod. 2005;20:2373–5.

    Article  PubMed  CAS  Google Scholar 

  2. Hugues JN, Cedrin Durnerin IC. Revisiting gonadotropin-releasing hormone agonist protocols and management of poor responses to gonadotropins. Hum Reprod Update. 1998;4:83–101.

    Article  PubMed  CAS  Google Scholar 

  3. Kowalik A, Barmat L, Damario M, Liu HC, Davis O, Rosenwaks Z. Ovarian estradiol production in vivo: inhibitory effect of leuprolide acetate. J Reprod Med. 1998;43:413–7.

    PubMed  CAS  Google Scholar 

  4. Olivennes F, Balaish-Allart J, Emperaire JC, Dechaud H, Alvares S, Moeau L, et al. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of LH-RH agonist (triptorelin). Fertil Steril. 2000;73:314–20.

    Article  PubMed  CAS  Google Scholar 

  5. AI-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotropin-releasing hormone antagonists for assisted conception. Cochrane Database Syst Rev. 2006;3:CD001750.

    Google Scholar 

  6. Shanbhag S, Aucott L, Bhattacharya S, Hamilton MA, McTavish AR. Interventions for “poor responders” to controlled ovarian hyperstimulation (COH) in in vitro fertilization (IVF). Cochrane Database Syst Rev. 2010;1:CD004379.

  7. Lainas TG, Sfontouris IA, Aorzovillis IZ, Petsas GK, Lainas GT, Alexopoulpu E, Kolibianakis EM. Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomized controlled trial (RCT). Hum Reprod. 2010;25:683–9.

    Article  PubMed  CAS  Google Scholar 

  8. Griesinger G, Venetis CA, Marx T, Diedrich K, Tarlatzis BC, Kolibianakis EM. Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis. Fertil Steril. 2008;90:1055–63.

    Article  PubMed  CAS  Google Scholar 

  9. Griesinger G, Kolibianakis EM, Venetis C, Diedrich K, Tarlatzis B. Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis. Fertil Steril. 2010;94:2382–4.

    Article  PubMed  CAS  Google Scholar 

  10. Klonoff-Cohen H, Natarajan L. The concerns during assisted reproductive technologies (CART) scale and pregnancy outcomes. Fertil Steril. 2004;81:982–8.

    Article  PubMed  Google Scholar 

  11. Devroey P, Aboulghar M, Velasco JG, Griesinger G, Humaidan P, Kolibianakis E, Ledger W, Toma C, Fauser BCJM. Improving the patient’s experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment. Hum Reprod. 2010;24:764–74.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Keiko Mekaru.

About this article

Cite this article

Mekaru, K., Yagi, C., Asato, K. et al. Comparison between the gonadotropin-releasing hormone antagonist protocol and the gonadotropin-releasing hormone agonist long protocol for controlled ovarian hyperstimulation in the first in vitro fertilization–embryo transfer cycle in an unspecified population of infertile couples. Reprod Med Biol 11, 79–83 (2012). https://doi.org/10.1007/s12522-011-0109-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12522-011-0109-2

Keywords

Navigation